Orchid acquires Alhenia – Strengthens role as global coating leader
Orchid Orthopedic Solutions (Orchid), which in 2011 was acquired by Altor Fund III, is pleased to announce it has acquired Alhenia AG, a leading provider of coated implants to orthopedic device manufacturers.
The combination of Alhenia and Orchid further strengthens Orchid’s position as the leading orthopedic coating company by adding new and novel coating technologies, geographic reach and an expanded customer base. The combination also creates an integrated local supply chain in Europe – from castings and forgings to fully finished, coated and packaged implants.
Alhenia is a world technology and quality leader in medical coatings and one of the leading medical coating companies in Europe. Alhenia is based in Switzerland and employs approximately 60 people.
“Orchid is very pleased to have the Alhenia founders and their employees join the Orchid team,” said Mike Miller, Orchid’s CEO.” With this strategic acquisition, Orchid is clearly the world technology leader in coating services for the global orthopedic market,” Miller continued.
”We are convinced that Orchid is the perfect platform to further expand the technologies and markets that Alhenia has developed in the last years, offering attractive opportunities for our specialized team and customers in the near future” said Jorge Garcia and Armando Salito – the founders of Alhenia.